Your browser doesn't support javascript.
loading
Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathies.
Eberl, Hanna; Rebs, Sabine; Hoppe, Stefanie; Sedaghat-Hamedani, Farbod; Kayvanpour, Elham; Meder, Benjamin; Streckfuss-Bömeke, Katrin.
Affiliation
  • Eberl H; Institute of Pharmacology and Toxicology, University of Würzburg, Germany.
  • Rebs S; Institute of Pharmacology and Toxicology, University of Würzburg, Germany; Clinic for Cardiology and Pneumology, Georg-August University Göttingen and DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany.
  • Hoppe S; Institute of Pharmacology and Toxicology, University of Würzburg, Germany.
  • Sedaghat-Hamedani F; Department of Internal Medicine III, University of Heidelberg, and DZHK, Partner Site Heidelberg, Germany.
  • Kayvanpour E; Department of Internal Medicine III, University of Heidelberg, and DZHK, Partner Site Heidelberg, Germany.
  • Meder B; Department of Internal Medicine III, University of Heidelberg, and DZHK, Partner Site Heidelberg, Germany.
  • Streckfuss-Bömeke K; Institute of Pharmacology and Toxicology, University of Würzburg, Germany; Clinic for Cardiology and Pneumology, Georg-August University Göttingen and DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany; Comprehensive Heart Failure Center (CHFC), University Clinic Würzb
Stem Cell Res ; 74: 103290, 2024 02.
Article in En | MEDLINE | ID: mdl-38141360
ABSTRACT
RBM20 mutations account for 3 % of genetic cardiomypathies and manifest with high penetrance and arrhythmogenic effects. Numerous mutations in the conserved RS domain have been described as causing dilated cardiomyopathy (DCM), whereas a particular mutation (p.R634L) drives development of a different cardiac phenotype left-ventricular non-compaction cardiomyopathy. We generated a mutation-induced pluripotent stem cell (iPSC) line in which the RBM20-LVNC mutation p.R634L was introduced into a DCM patient line with rescued RBM20-p.R634W mutation. These DCM-634L-iPSC can be differentiated into functional cardiomyocytes to test whether this RBM20 mutation induces development of the LVNC phenotype within the genetic context of a DCM patient.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Dilated / RNA-Binding Proteins / Induced Pluripotent Stem Cells / Cardiomyopathies Limits: Humans Language: En Journal: Stem Cell Res Year: 2024 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Dilated / RNA-Binding Proteins / Induced Pluripotent Stem Cells / Cardiomyopathies Limits: Humans Language: En Journal: Stem Cell Res Year: 2024 Document type: Article Affiliation country: Germany Country of publication: United kingdom